Ad is loading...
DWGHX
Price
$10.66
Change
-$0.07 (-0.65%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

DWGHX vs RNWFX

Header iconDWGHX vs RNWFX Comparison
Open Charts DWGHX vs RNWFXBanner chart's image
American Funds Dvlpg Wld Gr&Inc F2
Price$10.66
Change-$0.07 (-0.65%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
DWGHX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DWGHX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWGHX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. DWGHX (1.82B). DWGHX pays higher dividends than RNWFX: DWGHX (1.91) vs RNWFX (1.51). DWGHX was incepted earlier than RNWFX: DWGHX (11 years) vs RNWFX (23 years). DWGHX is a more actively managed with annual turnover of: 37.00 vs. RNWFX (32.00). DWGHX (250) and RNWFX (250) have matching initial minimum investment requirements. RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. DWGHX (9.36). RNWFX return over 5 years is better than : 17.17 vs. DWGHX (3.93).
DWGHXRNWFXDWGHX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD4.4067.09962%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets1.82B60.9B3%
Annual Yield % from dividends1.911.51127%
Returns for 1 year9.3611.5481%
Returns for 3 years-16.63-14.55114%
Returns for 5 years3.9317.1723%
Returns for 10 years7.0841.0017%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics